Loading…
Back To Schedule
Thursday, June 17 • 12:00pm - 1:00pm
#513 OD: NMPA Town Hall

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate

Regulatory speakers will present and discuss the following topics: NMPA's action plan on accelerating the advancement of Smart Drug Supervision, NMPA's initiative on regulatory science and an update from CDE on new drug review and approval.

Learning Objectives

Present and discuss the latest information on the NMPA's initiatives on regulatory science and drug supervision; Describe the update on drug review and approval.

Chair

Ling Su, PhD

Speaker

Digitalization Promotes Medical Products Intelligent Administration
Wenjia Qiang

NMPA Guidance and Progress in Real-World Evidence
Jun Zhao

A Brief Introduction of Regulatory Science Initiative of NMPA
Yue Yang, PhD, MS



Speakers
avatar for Ling Su

Ling Su

Research Fellow, Shenyang Pharmaceutical University Yeehong Business School, China
Dr. Ling Su is a Research Fellow in Shengyang Pharmaceutical University Yeehong Business School and a Venture Partner in Lilly Asia Ventures (LAV). He has 30 years of experience in drug regulatory and development. He had worked in various R&D management positions in the pharma industry... Read More →
avatar for Wenjia Qiang

Wenjia Qiang

Staff Member, Office of Big Data Management, Center for Information, NMPA, China
Miss Qiang is an engineer of the Center for Information, responsible for data collection, data curation, governance, sharing and exchange, and statistics and analysis related to drugs, cosmetics and medical devices. Miss Qiang has been at Center for Information for nearly 4 years... Read More →
avatar for Yue Yang

Yue Yang

Research Professor and Doctoral Supervisor, School of Pharmaceutical Sciences, Tsinghua University, China
Yue Yang is the researcher and doctoral supervisor at the School of Pharmacy. She is mainly engaged in research on regulatory science, pharmaceutical regulations and drug policy, member of the Expert Group on the revision of the Drug Administration Law, participated in the formulation... Read More →
avatar for Jun Zhao

Jun Zhao

Office of Statistics and Clinical Pharmacology, Center for Drug Evaluation, NMPA, China
Mr. Zhao is a statistical reviewer for oncology drugs, he participated in the development of 2 RWE guidelines, “Guidance on Using Real World Evidence to Support Drug Development and Decision-making” and “Guidance on Real World Data Used to Generate Real World Evidence”, He... Read More →


Thursday June 17, 2021 12:00pm - 1:00pm EDT
TBD Virtual Event Horsham, PA 19044
  09: Regulatory, Forum |   20: Early Access Content, Forum